DL
Delta Lloyd Portfolio holdings
AUM
$3.56B
1-Year Return
18.98%
This Quarter Return
+1.92%
1 Year Return
+18.98%
3 Year Return
+37.43%
5 Year Return
–
10 Year Return
–
AUM
$3.22B
AUM Growth
-$150M
(-4.4%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
25.16%
Holding
678
New
19
Increased
87
Reduced
191
Closed
15
Top Buys
| 1 |
Hasbro
HAS
|
$45.7M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$22.9M |
| 3 |
Johnson & Johnson
JNJ
|
$18.8M |
| 4 |
Procter & Gamble
PG
|
$17.9M |
| 5 |
Simon Property Group
SPG
|
$16.2M |
Top Sells
| 1 |
SPLS
Staples Inc
SPLS
|
$69.3M |
| 2 |
Medtronic
MDT
|
$60.2M |
| 3 |
Eastman Chemical
EMN
|
$49.5M |
| 4 |
Tapestry
TPR
|
$38.7M |
| 5 |
Pfizer
PFE
|
$25M |
Sector Composition
| 1 | Technology | 14.39% |
| 2 | Healthcare | 13.96% |
| 3 | Real Estate | 13.11% |
| 4 | Financials | 12.8% |
| 5 | Consumer Discretionary | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Mondelez International
MDLZ
$79.9B
| $2.64M | 0.08% |
73,259
-2,980
| -4% | -$108K |
|
152
Essex Property Trust
ESS
$17.3B
| $2.59M | 0.08% |
11,248
-246
| -2% | -$56.6K |
|
153
Teva Pharmaceuticals
TEVA
$21.7B
| $2.56M | 0.08% |
41,039
| – | – |
|
154
Ford
F
$46.7B
| $2.55M | 0.08% |
157,697
-3,497
| -2% | -$56.4K |
|
155
HP
HPQ
$27.4B
| $2.52M | 0.08% |
178,369
-9,252
| -5% | -$131K |
|
|
MON
156
DELISTED
Monsanto Co
MON
| $2.51M | 0.08% |
22,260
-1,903
| -8% | -$214K |
|
157
DuPont de Nemours
DD
$32.6B
| $2.5M | 0.08% |
25,816
-1,627
| -6% | -$157K |
|
158
Occidental Petroleum
OXY
$45.2B
| $2.47M | 0.08% |
33,944
-1,432
| -4% | -$104K |
|
159
Interface
TILE
$1.64B
| $2.42M | 0.08% |
116,461
-44,903
| -28% | -$933K |
|
|
KRFT
160
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $2.41M | 0.07% |
27,644
-408
| -1% | -$35.5K |
|
161
Badger Meter
BMI
$5.39B
| $2.4M | 0.07% |
80,000
+30,000
| +60% | +$899K |
|
162
Lockheed Martin
LMT
$108B
| $2.39M | 0.07% |
11,773
-295
| -2% | -$59.9K |
|
163
Thermo Fisher Scientific
TMO
$186B
| $2.35M | 0.07% |
17,518
| – | – |
|
164
Duke Energy
DUK
$93.8B
| $2.34M | 0.07% |
30,462
| – | – |
|
165
Danaher
DHR
$143B
| $2.31M | 0.07% |
40,432
| – | – |
|
166
Angi Inc
ANGI
$811M
| $2.3M | 0.07% |
39,198
-8,000
| -17% | -$470K |
|
167
EOG Resources
EOG
$64.4B
| $2.3M | 0.07% |
25,033
+264
| +1% | +$24.2K |
|
168
McKesson
MCK
$85.5B
| $2.29M | 0.07% |
10,135
| – | – |
|
169
TJX Companies
TJX
$155B
| $2.23M | 0.07% |
63,768
-756
| -1% | -$26.5K |
|
170
Blackrock
BLK
$170B
| $2.21M | 0.07% |
6,044
-37
| -0.6% | -$13.5K |
|
171
General Motors
GM
$55.5B
| $2.19M | 0.07% |
58,433
+1,743
| +3% | +$65.4K |
|
172
PNC Financial Services
PNC
$80.5B
| $2.19M | 0.07% |
23,476
| – | – |
|
173
Insulet
PODD
$24.5B
| $2.17M | 0.07% |
65,000
| – | – |
|
174
Target
TGT
$42.3B
| $2.12M | 0.07% |
25,793
| – | – |
|
175
NextEra Energy, Inc.
NEE
$146B
| $2.09M | 0.06% |
80,232
+2,124
| +3% | +$55.3K |
|